Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    Uncategorized Posts

    A system-level approach identifies HIF-2α as a,critical regulator of chondrosarcoma progression

    November 26th, 2023

    Chondrosarcomas, malignant cartilaginous neoplasms, are capable of transitioning to highly aggressive, metastatic, and treatment-refractory states, resulting in significant patient mortality.
    Here, we aim to uncover the transcriptional program…

    Read Article

    First full Analysis of the Chondrosarcoma Patient Registry set for November 30

    November 18th, 2023

    Read Article

    Constitutive activation of EGFR is associated with tumor progression and plays a prominent role in malignant phenotype of chondrosarcoma

    October 30th, 2023

    Constitutive activation of EGFR is associated with tumor progression and plays a prominent role in malignant phenotype of chondrosarcoma Jun Qin,1 Irfan Shaukat,1 Didier Mainard,1 Patrick Netter,1 Lydia Barré,1 and Mohamed Ouzzine1

    Author…

    Read Article

    Call for Action: Join the Chondrosarcoma Patient Registry before the first full analysis set for November 30.

    October 29th, 2023

    Chondrosarcoma Patient Registry

    Homepage

    On November 30 the Chondrosarcoma will conduct the first full statistical analysis of the Chondrosarcoma Patient Registry. The analysis will focus on detailed patient profiling. In…

    Read Article

    Videos from Virtual Dialogue 5 are posted on the Web Site.

    October 27th, 2023

    Videos from Virtual Dialogue 5 are posted on the Web Site.

    We invite you to go to the Chondrosarcoma Foundation web site to review the presentations and the open discussion from the Fifth International Virtual Dialogue recently held on October 4….

    Read Article

    New Publication: Chondrosarcoma: What You Need to Know

    October 26th, 2023

    New Publication: Chondrosarcoma: What You Need to Know

    A third publication created by the Chondrosarcoma Foundation’s Patient, Family, Caregiver Advisory Board and the Marketing / Graphics team at Inhibrx provides straightforward information on…

    Read Article

    CS Foundation Fund Raiser: Steppin’ for a Cause

    October 8th, 2023

    Steppin’ For A Cause: 5K Walk / Run

    October 21, 2023 10:00AM EST

    Allen’s Pond, Bowie, Maryland

    Please join us for our annual fund raising event to honor Shayna Kramer by carrying out her wish to help others that have the same rare bone cancer:…

    Read Article

    Last Call to Register for the Chondrosarcoma Foundation’s Virtual Dialogue

    October 1st, 2023

    Future Initiatives in the Diagnosis and Treatment of Chondrosarcoma

    Chondrosarcoma Foundation: Fifth International Virtual Dialogue (VIA Zoom)

    Date: Wednesday, October 4, 2023

    Time: 7:00PM – 9:00PM (EST / New York)

    Last chance to register. The…

    Read Article

    Clinico-genomic profiling of conventional and dedifferentiated chondrosarcomas reveals ,TP53 mutation to be associated with worse outcomes

    September 30th, 2023

    Paper recently published in Clinical Cancer Research on genetic sequencing of conventional and dedifferentiated chondrosarcoma from two of our board members at MD Anderson in Houston, Texas: Anthony Conley, M.D. and Shaan Mohahmad Razza, M.D.

    For…

    Read Article

    Chondrosarcoma Foundation Virtual Dialogue: October 4, 2023: 7:00PM – 9:00PM EST / New York time via Zoom

    September 18th, 2023

    Two weeks from this Wednesday.

    We want to encourage you to attend our upcoming Virtual Dialogue. We bring together the diverse group of clinical / research/ medical / sarcoma experts with chondrosarcoma patients, families and caregivers. The focus…

    Read Article
    Skip to content